{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:52:01Z","timestamp":1791867121387,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.iliver.2022.02.004","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T06:38:08Z","timestamp":1646894288000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"1","author":[{"given":"Xinhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.iliver.2022.02.004_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MOP.0000000000000779","article-title":"Diagnosis and management of hypopituitarism","volume":"31","author":"Yeliosof","year":"2019","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12020-016-1159-3","article-title":"Mortality in adults with hypopituitarism: a systematic review and meta-analysis","volume":"56","author":"Jasim","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.iliver.2022.02.004_bib3","first-page":"25","volume":"vol. 451","author":"Heidelbaugh","year":"2016"},{"issue":"47","key":"10.1016\/j.iliver.2022.02.004_bib4","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J Gastroenterol."},{"issue":"7","key":"10.1016\/j.iliver.2022.02.004_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.iliver.2022.02.004_bib7","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.iliver.2022.02.004_bib8","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"issue":"14","key":"10.1016\/j.iliver.2022.02.004_bib9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3748\/wjg.v25.i14.1741","article-title":"Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients","volume":"25","author":"Yuan","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.iliver.2022.02.004_bib10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"27","key":"10.1016\/j.iliver.2022.02.004_bib11","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \"two hit theory\" to \"multiple hit model","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"issue":"12","key":"10.1016\/j.iliver.2022.02.004_bib13","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/hmg\/ddy124","article-title":"NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects","volume":"27","author":"Sliz","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.004_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1874467208666150817111114","article-title":"Role of CYP2E1 in mitochondrial dysfunction and hepatic injury by alcohol and non-alcoholic substances","volume":"10","author":"Abdelmegeed","year":"2017","journal-title":"Curr Mol Pharmacol"},{"issue":"9","key":"10.1016\/j.iliver.2022.02.004_bib15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/thy.2018.0664","article-title":"Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists","volume":"29","author":"Sinha","year":"2019","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib17","article-title":"Hypothyroidism and nonalcoholic fatty liver disease - a chance association?","volume":"41","author":"Lugari","year":"2018","journal-title":"Horm Mol Biol Clin Invest"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10620-011-2006-2","article-title":"Prevalence of hypothyroidism in nonalcoholic fatty liver disease","volume":"57","author":"Pagadala","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.iliver.2022.02.004_bib20","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1089\/thy.2018.0257","article-title":"Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"28","author":"Mantovani","year":"2018","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2017.08.014","article-title":"Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis","volume":"16","author":"Kim","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.iliver.2022.02.004_bib22","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.cgh.2018.11.024","article-title":"Low-normal thyroid function is associated with advanced fibrosis among adults in the United States","volume":"17","author":"Kim","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.iliver.2022.02.004_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000454920","article-title":"Nonalcoholic fatty liver disease is not associated with thyroid hormone levels and hypothyroidism: a systematic review and meta-analysis","volume":"6","author":"Jaruvongvanich","year":"2017","journal-title":"Eur Thyroid J"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib24","first-page":"1","article-title":"Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population","volume":"154","author":"Martinez","year":"2020","journal-title":"Med Clin"},{"key":"10.1016\/j.iliver.2022.02.004_bib25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3389\/fendo.2018.00511","article-title":"A\u00a0renewed focus on the association between thyroid hormones and lipid metabolism","volume":"9","author":"Duntas","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.iliver.2022.02.004_bib26","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1210\/en.2012-1572","article-title":"Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway","volume":"153","author":"Goldberg","year":"2012","journal-title":"Endocrinology"},{"issue":"36","key":"10.1016\/j.iliver.2022.02.004_bib27","doi-asserted-by":"crossref","first-page":"34114","DOI":"10.1074\/jbc.M305417200","article-title":"Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2)","volume":"278","author":"Shin","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"10.1016\/j.iliver.2022.02.004_bib28","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ Res"},{"issue":"47","key":"10.1016\/j.iliver.2022.02.004_bib29","first-page":"5958","article-title":"Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport","volume":"16","author":"Pedrelli","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib30","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.dsx.2019.03.004","article-title":"ABCA1 and metabolic syndrome; a review of the ABCA1 role in HDL-VLDL production, insulin-glucose homeostasis, inflammation and obesity","volume":"13","author":"Babashamsi","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"10.1016\/j.iliver.2022.02.004_bib31","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1021\/bi0301643","article-title":"Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor","volume":"43","author":"Huuskonen","year":"2004","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3803\/EnM.2018.33.1.33","article-title":"Association of adipokines with development and progression of nonalcoholic fatty liver disease","volume":"33","author":"Boutari","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.iliver.2022.02.004_bib33","doi-asserted-by":"crossref","first-page":"26174","DOI":"10.1038\/srep26174","article-title":"Changes in profile of lipids and adipokines in patients with newly diagnosed hypothyroidism and hyperthyroidism","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.iliver.2022.02.004_bib34","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1073\/pnas.182420899","article-title":"PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2265.1998.00573.x","article-title":"Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects","volume":"49","author":"Pinkney","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.iliver.2022.02.004_bib36","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","article-title":"Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms","volume":"24","author":"Ueki","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.iliver.2022.02.004_bib37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3350\/cmh.2018.0011","article-title":"The Association of leptin with severity of non-alcoholic fatty liver disease: a population-based study","volume":"24","author":"Rotundo","year":"2018","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.iliver.2022.02.004_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cyto.2016.10.011","article-title":"Leptin in inflammation and autoimmunity","volume":"98","author":"La Cava","year":"2017","journal-title":"Cytokine"},{"issue":"24","key":"10.1016\/j.iliver.2022.02.004_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249368","article-title":"Unraveling the role of leptin in liver function and its relationship with liver diseases","volume":"21","author":"Martinez-Una","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.iliver.2022.02.004_bib40","first-page":"BC07","article-title":"Variations of adipokines and insulin resistance in primary hypothyroidism","volume":"11","author":"Kar","year":"2017","journal-title":"J\u00a0Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000495215","article-title":"Association of circulating adipsin, visfatin, and adiponectin with nonalcoholic fatty liver disease in adults: a case-control study","volume":"74","author":"Qiu","year":"2019","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.004_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5114\/pjp.2017.67583","article-title":"Expression of resistin in the liver of patients with non-alcoholic fatty liver disease","volume":"68","author":"Gierej","year":"2017","journal-title":"Pol J Pathol"},{"issue":"9","key":"10.1016\/j.iliver.2022.02.004_bib43","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1210\/jc.2013-1610","article-title":"Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients","volume":"98","author":"Klose","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.iliver.2022.02.004_bib44","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2337\/dc14-2515","article-title":"Hypothyroidism is a risk factor for new-onset diabetes: a cohort study","volume":"38","author":"Gronich","year":"2015","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib45","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1210\/jc.2004-1768","article-title":"Thyroid hormone responsive genes in cultured human fibroblasts","volume":"90","author":"Moeller","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/EJE-08-0797","article-title":"Studies of insulin resistance in patients with clinical and subclinical hypothyroidism","volume":"160","author":"Maratou","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.iliver.2022.02.004_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1749-6632.2002.tb04262.x","article-title":"Hyperglycemia and insulin resistance: possible mechanisms","volume":"967","author":"Tomas","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.iliver.2022.02.004_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/bs.pmbts.2015.10.008","article-title":"Effects of growth hormone on bone","volume":"138","author":"Tritos","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"4","key":"10.1016\/j.iliver.2022.02.004_bib49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/dmr.5610040406","article-title":"Growth hormone and metabolism","volume":"4","author":"Press","year":"1988","journal-title":"Diabetes Metab Rev"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-12-0252","article-title":"Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy","volume":"167","author":"Nishizawa","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.iliver.2022.02.004_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071447","article-title":"The role of growth hormone and insulin-like growth factor-I in the liver","volume":"18","author":"Takahashi","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ghir.2014.07.002","article-title":"Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency","volume":"24","author":"Matsumoto","year":"2014","journal-title":"Growth Hormone IGF Res"},{"issue":"8","key":"10.1016\/j.iliver.2022.02.004_bib53","doi-asserted-by":"crossref","first-page":"e44136","DOI":"10.1371\/journal.pone.0044136","article-title":"Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.iliver.2022.02.004_bib54","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygcen.2017.07.028","article-title":"The growth hormone signaling system: insights into coordinating the anabolic and catabolic actions of growth hormone","volume":"258","author":"Bergan-Roller","year":"2018","journal-title":"Gen Comp Endocrinol"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12072-007-9007-4","article-title":"Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease","volume":"1","author":"Ichikawa","year":"2007","journal-title":"Hepatol Int"},{"issue":"45","key":"10.1016\/j.iliver.2022.02.004_bib56","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.3748\/wjg.v16.i45.5693","article-title":"Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution","volume":"16","author":"Zaouali","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051308","article-title":"Insulin-like growth factor (IGF) system in liver diseases","volume":"19","author":"Adamek","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.004_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.6065\/apem.2017.22.3.145","article-title":"Effects of growth hormone on glucose metabolism and insulin resistance in human","volume":"22","author":"Kim","year":"2017","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tem.2017.11.001","article-title":"JAK\/STAT - emerging players in metabolism","volume":"29","author":"Dodington","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib60","first-page":"541","article-title":"Influence of insulin on growth hormone secretion, level and growth hormone signalling","volume":"69","author":"Qiu","year":"2017","journal-title":"Sheng Li Xue Bao"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051529","article-title":"The CD36-PPARgamma pathway in metabolic disorders","volume":"19","author":"Marechal","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.iliver.2022.02.004_bib62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.plipres.2013.12.001","article-title":"Regulation of energy metabolism by long-chain fatty acids","volume":"53","author":"Nakamura","year":"2014","journal-title":"Prog Lipid Res"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib63","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bcpt.13190","article-title":"A\u00a0role of peroxisome proliferator-activated receptor gamma in non-alcoholic fatty liver disease","volume":"124","author":"Skat-Rordam","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.iliver.2022.02.004_bib64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib65","doi-asserted-by":"crossref","first-page":"e36785","DOI":"10.1371\/journal.pone.0036785","article-title":"Scavenger receptor CD36 expression contributes to adipose tissue inflammation and cell death in diet-induced obesity","volume":"7","author":"Cai","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.iliver.2022.02.004_bib66","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI0214596","article-title":"Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice","volume":"109","author":"Hajri","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib67","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2010.08.046","article-title":"Phosphorylation of sterol regulatory element-binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes","volume":"213","author":"Kotzka","year":"2010","journal-title":"Atherosclerosis"},{"issue":"34","key":"10.1016\/j.iliver.2022.02.004_bib68","doi-asserted-by":"crossref","first-page":"23332","DOI":"10.1074\/jbc.M113.526343","article-title":"Hepatic differentiated embryo-chondrocyte-expressed gene 1 (Dec1) inhibits sterol regulatory element-binding protein-1c (Srebp-1c) expression and alleviates fatty liver phenotype","volume":"289","author":"Shen","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib69","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.jid.5701155","article-title":"IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase\/Akt pathway","volume":"128","author":"Smith","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.iliver.2022.02.004_bib70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12885-015-1452-1","article-title":"17beta-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells","volume":"15","author":"Belkaid","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.iliver.2022.02.004_bib71","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0015-0282(16)58197-7","article-title":"Estrogen biosynthesis--regulation, action, remote effects, and value of monitoring in ovarian stimulation cycles","volume":"65","author":"Shoham","year":"1996","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.iliver.2022.02.004_bib72","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaad.2018.08.062","article-title":"Androgens in women: androgen-mediated skin disease and patient evaluation","volume":"80","author":"Bienenfeld","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.004_bib73","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/en.2018-00529","article-title":"History of estrogen: its purification, structure, synthesis,\u00a0\u200bbiologic actions, and clinical implications","volume":"160","author":"Santen","year":"2019","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib74","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/cen.13141","article-title":"ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres","volume":"85","author":"O'Reilly","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"48","key":"10.1016\/j.iliver.2022.02.004_bib75","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1556\/OH.2009.28749","article-title":"[Role of the endocrine system in the pathogenesis of non-alcoholic fatty liver disease]","volume":"150","author":"Hagymasi","year":"2009","journal-title":"Orv Hetil"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib76","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/db11-1718","article-title":"Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance","volume":"62","author":"Zhu","year":"2013","journal-title":"Diabetes"},{"issue":"39","key":"10.1016\/j.iliver.2022.02.004_bib77","doi-asserted-by":"crossref","first-page":"11053","DOI":"10.3748\/wjg.v21.i39.11053","article-title":"Endocrine causes of nonalcoholic fatty liver disease","volume":"21","author":"Marino","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib78","first-page":"99","article-title":"Estradiol regulates insulin signaling and inflammation in adipose tissue","volume":"17","author":"Shen","year":"2014","journal-title":"Horm Mol Biol Clin Invest"},{"key":"10.1016\/j.iliver.2022.02.004_bib79","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of estrogens in the regulation of liver lipid metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib80","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.fertnstert.2007.06.011","article-title":"Key lipogenic gene expression can\u00a0be\u00a0decreased by estrogen in human adipose tissue","volume":"90","author":"Lundholm","year":"2008","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.iliver.2022.02.004_bib81","doi-asserted-by":"crossref","first-page":"158521","DOI":"10.1016\/j.bbalip.2019.158521","article-title":"Estrogen-related receptor gamma controls sterol regulatory element-binding protein-1c expression and alcoholic fatty liver","volume":"1864","author":"Kim","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.iliver.2022.02.004_bib82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmet.2018.09.002","article-title":"Activation of estrogen receptor alpha induces beiging of adipocytes","volume":"18","author":"Santos","year":"2018","journal-title":"Mol Metabol"},{"issue":"2","key":"10.1016\/j.iliver.2022.02.004_bib83","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1620\/tjem.231.101","article-title":"Adipose tissue-derived stem cells treated with estradiol enhance survival of autologous fat transplants","volume":"231","author":"Luo","year":"2013","journal-title":"Tohoku J Exp Med"},{"issue":"10","key":"10.1016\/j.iliver.2022.02.004_bib84","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.metabol.2004.05.003","article-title":"Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL\/6J mice","volume":"53","author":"Jeong","year":"2004","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yfrne.2013.08.001","article-title":"Estrogen: a master regulator of bioenergetic systems in the brain and body","volume":"35","author":"Rettberg","year":"2014","journal-title":"Front Neuroendocrinol"},{"issue":"11","key":"10.1016\/j.iliver.2022.02.004_bib86","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1289\/ehp.1408663","article-title":"Arsenic exposure and glucose intolerance\/insulin resistance in estrogen-deficient female mice","volume":"123","author":"Huang","year":"2015","journal-title":"Environ Health Perspect"},{"issue":"4","key":"10.1016\/j.iliver.2022.02.004_bib87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1556\/OH.2012.29287","article-title":"[Interactions of insulin and estrogen in the regulation of cell proliferation and carcinogenesis]","volume":"153","author":"Suba","year":"2012","journal-title":"Orv Hetil"},{"issue":"10","key":"10.1016\/j.iliver.2022.02.004_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101259","article-title":"Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"8","author":"Lee","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib89","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.dsx.2020.07.049","article-title":"Nonalcoholic fatty liver disease in males with low testosterone concentrations","volume":"14","author":"Polyzos","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.004_bib90","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5604\/01.3001.0009.8593","article-title":"Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.004_bib91","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0029-1202774","article-title":"Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate","volume":"118","author":"Haider","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.iliver.2022.02.004_bib92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1471-230X-12-69","article-title":"A\u00a0low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.iliver.2022.02.004_bib93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2605.2009.00953.x","article-title":"Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men","volume":"33","author":"Volzke","year":"2010","journal-title":"Int J Androl"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib94","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/anae.14963","article-title":"Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: guidelines from the association of anaesthetists, the royal college of physicians and the society for endocrinology UK","volume":"75","author":"Woodcock","year":"2020","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.004_bib95","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11102-018-00932-w","article-title":"Neuroendocrine changes after aneurysmal subarachnoid haemorrhage","volume":"22","author":"Karaca","year":"2019","journal-title":"Pituitary"},{"issue":"4","key":"10.1016\/j.iliver.2022.02.004_bib96","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/00365510152379030","article-title":"Effects of short-term treatment with corticotropin on the serum apolipoprotein pattern","volume":"61","author":"Arnadottir","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"10.1016\/j.iliver.2022.02.004_bib97","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.transproceed.2006.02.090","article-title":"Short-term administration of ACTH improves plasma lipid profile and renal function in kidney transplant patients","volume":"38","author":"He","year":"2006","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.iliver.2022.02.004_bib98","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.metabol.2006.04.001","article-title":"The effects of adrenocorticotrophic hormone and an equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteins","volume":"55","author":"Berg","year":"2006","journal-title":"Metabolism"},{"issue":"42","key":"10.1016\/j.iliver.2022.02.004_bib99","doi-asserted-by":"crossref","first-page":"38680","DOI":"10.1074\/jbc.M104659200","article-title":"ACTH decreases the expression and secretion of apolipoprotein B in HepG2 cell cultures","volume":"276","author":"Xu","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iliver.2022.02.004_bib100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-511X-9-48","article-title":"Lipid synthesis and secretion in HepG2 cells is not affected by ACTH","volume":"9","author":"Skoog","year":"2010","journal-title":"Lipids Health Dis"},{"issue":"7","key":"10.1016\/j.iliver.2022.02.004_bib101","article-title":"Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL)\u2014but not of oxidized LDL and native or oxidized lipoprotein(a) [LP(a)]\u2014in HEPG2 cells: No evidence for Lp(a) catabolism via the LDL-receptor","volume":"46","author":"Werner","year":"1997","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.iliver.2022.02.004_bib102","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbrc.2018.03.048","article-title":"Ablation of prolactin receptor increases hepatic triglyceride accumulation","volume":"498","author":"Shao","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.iliver.2022.02.004_bib103","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2018.01.035","article-title":"Prolactin improves hepatic steatosis via CD36 pathway","volume":"68","author":"Zhang","year":"2018","journal-title":"J\u00a0Hepatol"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947822000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947822000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:36:40Z","timestamp":1757425000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947822000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2772947822000068"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2022.02.004","relation":{},"ISSN":["2772-9478"],"issn-type":[{"value":"2772-9478","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2022.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}]}}